Professor Andrew Nunn

For half a century Professor Andrew Nunn has been at the forefront of research efforts to improve the treatment of tuberculosis (TB). He has played a major role in many of the most important studies that have resulted in better treatments for people infected with TB throughout the world.

Professor Andrew Nunn has been working in clinical trials and epidemiological research since 1966, when he joined the Medical Research Council (MRC) Tuberculosis & Chest Diseases Unit as a Statistician, becoming a Senior Statistician in 1972. Until 1986 he was directly involved in the design, conduct and analysis of the programme of trials which led to the worldwide adoption of short-course chemotherapy for tuberculosis (TB). He then joined the MRC’s Uganda AIDS Programme which researched the dynamics of the human immunodeficiency virus (HIV) epidemic in a rural African environment. On his return to the UK, he became Head of the Division Without Portfolio within the newly formed MRC Clinical Trials Unit with responsibility for developing trials in neglected areas. Prof Nunn also contributed to research in other areas of respiratory disease from the first trial of inhaled steroids to surveys of asthma deaths.

Make a nomination now for the 2019 Awards